# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JMP Securities analyst David Turkaly maintains Neuronetics (NASDAQ:STIM) with a Market Outperform and lowers the price targe...
Canaccord Genuity analyst William Plovanic maintains Neuronetics (NASDAQ:STIM) with a Buy and lowers the price target from $...
William Blair analyst Margaret Kaczor downgrades Neuronetics (NASDAQ:STIM) from Outperform to Market Perform.
Neuronetics to acquire Greenbrook TMS (OTC: GBNHF) in an all-stock deal, doubling revenue to $145M. The combined company expect...